Wells Fargo’s Amsurg Corp. 5.25% Mandatory Convertible Pft Stk Ser A-1 AMSGP Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2016
Q4
Sell
-62,300
Closed -$7.9M 6653
2016
Q3
$7.9M Buy
62,300
+50,000
+407% +$6.5M ﹤0.01% 1932
2016
Q2
$1.78M Sell
12,300
-5,300
-30% -$770K ﹤0.01% 3054
2016
Q1
$2.48M Buy
17,600
+17,000
+2,833% +$2.29M ﹤0.01% 2772
2015
Q4
$87K Buy
600
+400
+200% +$60.2K ﹤0.01% 5014
2015
Q3
$30K Hold
200
﹤0.01% 5425
2015
Q2
$28K Buy
+200
New +$26.6K ﹤0.01% 5495
2014
Q4
Sell
-35,200
Closed -$3.76M 6578
2014
Q3
$3.76M Buy
+35,200
New +$3.79M ﹤0.01% 2538

Wells Fargo's AMSGP Position: Q4 2016 in Review

Wells Fargo sold out of Amsurg Corp. 5.25% Mandatory Convertible Pft Stk Ser A-1 (AMSGP) in Q4 2016, closing a stake of 62,300 shares — an estimated $7.9M sold.

Wells Fargo first reported a position in AMSGP in Q3 2014 and held it in 7 quarters. The position peaked at $7.9M in Q3 2016. 0 funds tracked by Wall St. Rank hold AMSGP as of Q4 2016.

  • Wells Fargo reported no remaining Amsurg Corp. 5.25% Mandatory Convertible Pft Stk Ser A-1 position as of Q4 2016 after selling out during the quarter.
  • Wells Fargo sold 62,300 Amsurg Corp. 5.25% Mandatory Convertible Pft Stk Ser A-1 shares in Q4 2016, an estimated $7.9M.
  • Wells Fargo first reported a position in Amsurg Corp. 5.25% Mandatory Convertible Pft Stk Ser A-1 in Q3 2014 and held it in 7 quarters.
  • Wells Fargo's Amsurg Corp. 5.25% Mandatory Convertible Pft Stk Ser A-1 position peaked at $7.9M in Q3 2016.
  • 0 funds tracked by Wall St. Rank held Amsurg Corp. 5.25% Mandatory Convertible Pft Stk Ser A-1 as of Q4 2016.

Based on Wells Fargo's 13F filing for Q4 2016, filed 1 Feb 2017.